RELIEF Therapeutics Holding AG
Biopharmaceutical company developing and commercializing therapies for rare diseases.
RLF | SW
Overview
Corporate Details
- ISIN(s):
- CH1251125998
- LEI:
- 506700IT19260EVD7916
- Country:
- Switzerland
- Address:
- avenue de Sécheron 15, 1202 Genève
- Sector:
- Manufacturing
Description
RELIEF Therapeutics Holding AG is a commercial-stage biopharmaceutical company focused on developing and commercializing novel, patent-protected therapies for specialty, rare, and ultra-rare diseases. The company's primary mission is to address significant unmet medical needs, particularly in areas such as rare metabolic disorders, by advancing treatment paradigms. It commercializes its products through a network of selected partners, aiming to deliver therapeutic solutions that significantly improve the condition and quality of life for patients. The portfolio includes a targeted clinical development pipeline and proprietary drug delivery platform technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-23 07:00 |
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Nex…
|
English | 14.9 KB | ||
| 2025-12-23 01:00 |
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Nex…
|
English | 12.8 KB | ||
| 2025-12-15 07:00 |
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze …
|
English | 11.3 KB | ||
| 2025-12-15 01:00 |
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze …
|
English | 9.1 KB | ||
| 2025-11-25 07:00 |
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook …
|
English | 11.1 KB | ||
| 2025-11-25 01:00 |
Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook …
|
English | 8.4 KB | ||
| 2025-11-14 18:20 |
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
|
English | 12.9 KB | ||
| 2025-11-14 01:00 |
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
|
English | 10.3 KB | ||
| 2025-10-29 07:00 |
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Stud…
|
English | 12.2 KB | ||
| 2025-10-29 01:00 |
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Stud…
|
English | 10.0 KB | ||
| 2025-10-24 06:59 |
Relief Therapeutics Convenes Extraordinary General Meeting
|
English | 12.0 KB | ||
| 2025-10-24 02:00 |
Relief Therapeutics Convenes Extraordinary General Meeting
|
English | 9.5 KB | ||
| 2025-10-08 07:00 |
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreemen…
|
English | 19.8 KB | ||
| 2025-10-08 02:00 |
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreemen…
|
English | 17.3 KB | ||
| 2025-08-14 07:00 |
Relief Therapeutics Publishes 2025 Half-Year Report
|
English | 9.0 KB |
Automate Your Workflow. Get a real-time feed of all RELIEF Therapeutics Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RELIEF Therapeutics Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RELIEF Therapeutics Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
